Correlation Between SCANDMEDICAL SOLDK-040 and Eli Lilly

Can any of the company-specific risk be diversified away by investing in both SCANDMEDICAL SOLDK-040 and Eli Lilly at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SCANDMEDICAL SOLDK-040 and Eli Lilly into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between SCANDMEDICAL SOLDK 040 and Eli Lilly and, you can compare the effects of market volatilities on SCANDMEDICAL SOLDK-040 and Eli Lilly and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SCANDMEDICAL SOLDK-040 with a short position of Eli Lilly. Check out your portfolio center. Please also check ongoing floating volatility patterns of SCANDMEDICAL SOLDK-040 and Eli Lilly.

Diversification Opportunities for SCANDMEDICAL SOLDK-040 and Eli Lilly

0.1

Correlation Coefficient

SCANDMEDICAL SOLDK-040  Eli Lilly

Average diversification

The 3 months correlation between SCANDMEDICAL and Eli is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding SCANDMEDICAL SOLDK 040 and Eli Lilly and in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eli Lilly and SCANDMEDICAL SOLDK-040 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SCANDMEDICAL SOLDK 040 are associated (or correlated) with Eli Lilly. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eli Lilly has no effect on the direction of SCANDMEDICAL SOLDK-040 i.e., SCANDMEDICAL SOLDK-040 and Eli Lilly go up and down completely randomly.

Pair Corralation between SCANDMEDICAL SOLDK-040 and Eli Lilly

Assuming the 90 days horizon SCANDMEDICAL SOLDK 040 is expected to generate 0.91 times more return on investment than Eli Lilly. However, SCANDMEDICAL SOLDK 040 is 1.1 times less risky than Eli Lilly. It trades about 0.01 of its potential returns per unit of risk. Eli Lilly and is currently generating about -0.22 per unit of risk. If you would invest  71.00  in SCANDMEDICAL SOLDK 040 on October 24, 2024 and sell it today you would earn a total of  0.00  from holding SCANDMEDICAL SOLDK 040 or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	94.44%
Values	Daily Returns

SCANDMEDICAL SOLDK 040  vs.  Eli Lilly and

SCANDMEDICAL SOLDK 040

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days SCANDMEDICAL SOLDK 040 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Eli Lilly

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Eli Lilly and has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with SCANDMEDICAL SOLDK-040 and Eli Lilly

The main advantage of trading using opposite SCANDMEDICAL SOLDK-040 and Eli Lilly positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SCANDMEDICAL SOLDK-040 position performs unexpectedly, Eli Lilly can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eli Lilly will offset losses from the drop in Eli Lilly's long position.

The idea behind SCANDMEDICAL SOLDK 040 and Eli Lilly and pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.